LeBlanc and coworkers reported that glioblastoma-derived PDE largely retain genetic and transcriptomic heterogeneity of parent tumors, enabling the dissection of glioblastoma heterogeneity evolution during disease progression and treatment response (15). This evidence concerns the gene ALDH7A1 and glioblastoma.